Advancing Your Innovation: Navigating the Complexity of Stable Cell Line Development
Join experts from ProteoGenix and Eurofins as they share strategies and solutions to streamline stable cell line development, ensuring high yields, clonal homogeneity, and seamless GMP transitions for biopharmaceutical success.
Cutting Edge Conversations 2022
The Cutting Edge Conversations series offers a deep dive into specific research areas and focused insights regarding market-relevant processes from respected firms in the industry.
#ExpertAnswers: Luke Holloway on Protein Characterization
Luke Holloway reviews light scattering-based methods for protein characterization and explains their utility in understanding aggregation propensity of monoclonal antibodies.
Using Chemical Denaturants and Light Scattering to Determine Aggregation Propensity of Biopharmaceuticals
Dr. Luke Holloway reviews light scattering-based methods for protein characterization and explains their utility, when combined with partially denaturing buffers, in understanding aggregation propensity of monoclonal antibodies.
Detection of Protein Aggregation During Biopharmaceutical Development: The Role of Orthogonal Techniques
Dr. Danny Chou discusses the opportunities and challenges in orthogonal particle analysis, and how flow imaging microscopy and light obscuration can be used for formulation development and quality control.
